… We have previously reported that IgG can be expressed in myeloblasts from patients with
acute myeloid leukemia (AML) and plays a role in the proliferation and apoptosis of leukemic …

… associated with decreased chemotherapy response. Furthermore, higher aberrant CD56
expression … ML-DS compared to non-DS AML was not associated with any poor outcome [17]. …

… CD56 dim CD16 + NK cells, we evaluated the expression of Ki-67, NKG2D, NKG2A and
granzyme B in the CD56 … SFTS patients (including 9 with mild disease and 9 with severe disease…

… more than 260 million people worldwide and has imposed an … Several risk factors associated
with unfavorable outcome … to the severe and critical phases of the disease is related to an …

… However, the association between the expression of CD56 … LEN did not overcome the poor
prognosis of CD56 – MM; … this study suggest that CD56 – MM has a poor prognosis, even in …

… of CD56 expression was a poor prognostic factor for patients with … prognostic value of CD56
in NDMM. This study aimed to evaluate the prognostic value of CD56 expression for patients …

… expression of CD56 in AML is present in 13-29% of cases with high frequency in AML M2,
M3 and M5. It identifies a subset of patients with a bad prognosis as … , CD56 expression was …

… CD56 + T cells was significantly higher than that of CD56 - T cells, which include cytotoxic
T cells. Antigen… of AKI is thought to contribute to the poor prognosis of SA-AKI; therefore, it is …

… CD56 … expression of CD56 increased and that the expression of CD3 was not different after
PDT. The results also indirectly indicated that the overall count of NK cells in the 10 patients …

… lead to a worse prognosis. Recent studies have shown that the expression of CD56, CD34,
… FLT3-ITD) marker is associated with poor prognosis [Citation8,Citation10–12]. However, the …